Bioniche total revenues fall in FY 11 - Pharmaceutical Business review

15 Sep 2011

Bioniche total revenues fall in FY 11

Bioniche Life Sciences has reported total revenues of C$36.04m for the fiscal year ended 30 June 2011, against C$45.9m for the same period in 2010.

The company has posted net loss of C$15.35m, as compared to net loss of C$1.59m for the year ago period.

The basic and fully-diluted net loss per share for fiscal 2011 is ($0.17), as compared to a net loss per share of ($0.02) in Fiscal 2010.

Bioniche is a Canada-based developer, manufacturer and marketer of proprietary products for human and animal health markets worldwide.

Drug Discovery